Faberidilactone A, a Sesquiterpene Dimer, Inhibits Hepatocellular Carcinoma Progression Through Apoptosis, Ferroptosis, and Anti-Metastatic Mechanisms
Open Access
Abstract
Cancer remains a significant global public health challenge, with hepatocellular carcinoma (HCC) ranking among the top five malignancies in terms of mortality. Faberidilactone A, a sesquiterpenoid dimer isolated from Inula japonica, exhibits potent cytotoxicity against various human tumor cell lines and demonstrates remarkable antitumor potential. In vitro studies using HepG2 cells revealed that faberidilactone A induces apoptosis and ferroptosis, causes cell cycle arrest, enhances the production of intracellular reactive oxygen species (ROS), and disrupts mitochondrial function. Mechanistic investigations via Western blot analysis indicated that faberidilactone A impedes HepG2 cell proliferation by modulating the signal transducer and activator of the transcription 3 (STAT3) signaling pathway and inhibits metastasis by affecting the focal adhesion kinase (FAK) pathway. In vivo experiments using a zebrafish model demonstrated that faberidilactone A effectively suppresses the dissemination and metastasis of HepG2 cells and exhibits anti-angiogenic properties. When the concentration of faberidilactone A reached 10 µM, the inhibition rates of tumor proliferation, migration, and intersegmental vessels (ISVs) length were 76.9%, 72.6%, and 46.2%, respectively. These findings underscore the therapeutic potential of faberidilactone A as a promising agent for HCC treatment.Keywords
Funding Information
- National Natural Science Foundation of China (22177054, QJJ [2022] 422)
- Guizhou Medical University (22177054, QJJ [2022] 422)
This publication has 37 references indexed in Scilit:
- MEHP induced mitochondrial damage by promoting ROS production in CIK cells, leading to apoptosis, autophagy, cell cycle arrestComparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 2024
- ROS: A “booster” for chronic inflammation and tumor metastasisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2024
- A novel selective FAK inhibitor E2 inhibits ovarian cancer metastasis and growth by inducing cytotoxic autophagyBiochemical Pharmacology, 2024
- Sanggenol L induces ferroptosis in non-small cell lung cancer cells via regulating the miR-26a-1-3p/MDM2/p53 signaling pathwayBiochemical Pharmacology, 2024
- Modification of a natural diterpene and its antitumor mechanism: Promoting apoptosis, suppressing migration, and inhibiting angiogenesisArabian Journal of Chemistry, 2024
- Artesunate-loaded solid lipid nanoparticles resist esophageal squamous cell carcinoma by inducing Ferroptosis through inhibiting the AKT/mTOR signalingCellular Signalling, 2024
- Design, Synthesis and Antitumor Activity of FAK/PLK1 Dual Inhibitors with Quinazolinone as the SkeletonChemistry & Biodiversity, 2023
- Wnt/β-catenin signaling pathway-a versatile player in apoptosis and autophagyBiochimie, 2023
- Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancerCell Metabolism, 2022
- Targeted therapy for hepatocellular carcinoma: Challenges and opportunitiesCancer Letters, 2019